Infantile hemangioma - Clinical resolution with 5% imiquimod cream

被引:75
作者
Martinez, MI
Sanchez-Carpintero, I
North, PE
Mihm, MC
机构
[1] Massachusetts Gen Hosp, Div Dermatopathol, Boston, MA 02114 USA
[2] Clin Americas, San Juan, PR USA
[3] Univ Navarra Clin, Navarra, Spain
[4] Harvard Univ, Boston, MA 02115 USA
[5] Arkansas Childrens Hosp, Little Rock, AR 72202 USA
[6] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
关键词
D O I
10.1001/archderm.138.7.881
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:881 / 884
页数:4
相关论文
共 19 条
[1]   Imiquimod: a novel treatment for lentigo maligna [J].
Ahmed, I ;
Berth-Jones, J .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (04) :843-845
[2]   Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy [J].
Barlow, CF ;
Priebe, CJ ;
Mulliken, JB ;
Barnes, PD ;
Mac Donald, D ;
Folkman, J ;
Ezekowitz, RAB .
JOURNAL OF PEDIATRICS, 1998, 132 (03) :527-530
[3]   Treatment of genital warts with an immune-response modifier (imiquimod) [J].
Beutner, KR ;
Spruance, SL ;
Hougham, AJ ;
Fox, TL ;
Owens, ML ;
Douglas, JM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (02) :230-239
[4]   Congenital hemangioma: Evidence of accelerated involution [J].
Boon, LM ;
Enjolras, O ;
Mulliken, JB .
JOURNAL OF PEDIATRICS, 1996, 128 (03) :329-335
[5]   Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis [J].
Coughlin, CM ;
Salhany, KE ;
Gee, MS ;
LaTemple, DC ;
Kotenko, S ;
Ma, XJ ;
Gri, G ;
Wysocka, M ;
Kim, JE ;
Liu, L ;
Liao, F ;
Farber, JM ;
Pestka, S ;
Trinchieri, G ;
Lee, WMF .
IMMUNITY, 1998, 9 (01) :25-34
[6]  
Dahl MV, 2000, J AM ACAD DERMATOL, V43, pS1, DOI 10.1067/mjd.2000.107809
[7]  
Duda DG, 2000, CANCER RES, V60, P1111
[8]   INTERFERON ALFA-2A THERAPY FOR LIFE-THREATENING HEMANGIOMAS OF INFANCY [J].
EZEKOWITZ, RAB ;
MULLIKEN, JB ;
FOLKMAN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22) :1456-1463
[9]  
Hengge UR, 2001, ARCH DERMATOL, V137, P709
[10]   Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463 [J].
Imbertson, LM ;
Beaurline, JM ;
Couture, AM ;
Gibson, SJ ;
Smith, RMA ;
Miller, RL ;
Reiter, MJ ;
Wagner, TL ;
Tomai, MA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (05) :734-739